Shandong Weigao Orthopaedic Device Stock Forum

Shandong Weigao Orthopaedic Device's falling ROCE and revenue, despite increased capital use, may suggest a loss of competitive edge or market share. The 51% stock depreciation over the past year seems to mirror these negative trends.

Despite recent revenue decline, investor confidence remains high in Shandong Weigao's prospects for significant growth, thus paying higher for the stock. Stock price likely to stay strong unless growth disappoints.